HomeBPMC • NASDAQ
add
Blueprint Medicines Corp
Previous close
$90.63
Day range
$86.72 - $90.56
Year range
$72.25 - $121.90
Market cap
5.55B USD
Avg Volume
605.76K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Sep 2024info | Y/Y change |
---|---|---|
Revenue | 128.18M | 126.61% |
Operating expense | 175.23M | -3.19% |
Net income | -56.28M | 57.91% |
Net profit margin | -43.90 | 81.43% |
Earnings per share | -0.89 | 59.55% |
EBITDA | -45.11M | 64.23% |
Effective tax rate | -0.49% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Sep 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 734.17M | 2.97% |
Total assets | 1.20B | 8.54% |
Total liabilities | 886.50M | -1.79% |
Total equity | 313.15M | — |
Shares outstanding | 63.53M | — |
Price to book | 18.38 | — |
Return on assets | -10.19% | — |
Return on capital | -11.62% | — |
Cash Flow
Net change in cash
(USD) | Sep 2024info | Y/Y change |
---|---|---|
Net income | -56.28M | 57.91% |
Cash from operations | -13.64M | 86.95% |
Cash from investing | 29.95M | 412.45% |
Cash from financing | 18.38M | -81.32% |
Net change in cash | 35.28M | 317.64% |
Free cash flow | 19.62M | 129.42% |
About
Founded
2008
Website
Employees
638